4. Technology Infrastructure
Bricopia's moat is its hardware. The platform integrates the cell-banking industry's leading automated processing and storage technologies: the only FDA-registered automation stack of its kind.
The Automation Stack
| Technology | Description |
|---|---|
| AXP® II | FDA 510(k)-cleared automated cord-blood cell-processing system; 1.4M+ purification procedures performed worldwide. |
| PXP-1000® | FDA 510(k)-cleared, closed, automated immune-cell isolation platform; the world's first automated immune-cell banking technology and cGMP-compliant. |
| BioArchive® | FDA 510(k)-cleared clinical-grade robotic cryogenic storage; all four FDA-approved cord-blood prescription (BLA) licenses use it. |
Through ThermoGenesis, Bricopia has been the cord-blood industry's sole automation-equipment supplier since 2022. Roughly 90% of US FDA-approved clinical-grade CBUs are stored in BioArchive® systems, with 300+ systems deployed across 130+ institutions in 30+ countries.
Deployment Footprint
| Metric | Value |
|---|---|
| BioArchive® systems deployed | 300+ |
| Institutions served | 130+ |
| Countries and regions | 30+ |
| Automated CBU procedures | 1.4M+ |
End-to-End Pipeline
Figure 4.1 in the source whitepaper shows the end-to-end Bricopia pipeline from collection to tokenization:
- Collection: CBU collected at FDA-compliant facilities.
- Processing: automated purification through AXP® II / PXP-1000®.
- Storage: robotic cryogenic vault through BioArchive®.
- Registry: private blockchain record with Proof of Process and Proof of Quality.
- Tokenization: issued as BRIC and BRICO.
Meeting the Three Core Requirements of an RWA
A credible real-world asset must be counterfeit-resistant, mapped one-to-one to its physical counterpart, and independently auditable. Manual cell-bank operations cannot meet these conditions; Bricopia's automated AXP® / BioArchive® systems can.
| RWA requirement | Legacy manual storage | Bricopia automated stack |
|---|---|---|
| Anti-counterfeiting & real-time monitoring | Hard to prevent tampering; transient warming degrades samples. | Real-time, gap-free sample tracking. |
| One-to-one asset correspondence | No individual, traceable mapping. | Each unit individually tracked and mapped. |
| Third-party auditability | No immutable record for auditors. | FDA 510(k) system with processing-data monitoring. |
BioArchive® is positioned as the gold-standard "smart vault" for storing "cell gold": automated, fast, efficient, and audit-ready.